Inspire Medical (INSP) | Financial Analysis & Statements

Inspire Medical Systems, Inc. | Mid-cap | Healthcare

129,71 US$

1,99 %

| Inspire Medical Stock Comparison:

Inspire Medical vs Abbott Laboratories Inspire Medical vs Boston Scientific Inspire Medical vs Masimo Inspire Medical vs Globus Medical Inspire Medical vs Bio-Rad Inspire Medical vs S&P 500 | Market

Overview Income Statement Balance Sheet Cash Flow Key Ratios Comparison

Financial Overview

Latest Annual: 2024

Income Metrics

Revenue 802,8M

Gross Profit 679,8M 84,68 %

Operating Income 36,1M 4,49 %

Net Income 53,5M 6,67 %

EPS (Diluted) 1,75 US$

Balance Sheet Metrics

Total Assets 808,4M

Total Liabilities 118,7M

Shareholders Equity 689,7M

Debt to Equity 0,17

Cash Flow Metrics

Operating Cash Flow 129,4M

Free Cash Flow 91,1M

Revenue & Profitability Trend

Income Statement

Metric	2024	2023	2022	2021	2020
Revenue	802,8M	624,8M	407,9M	233,4M	115,4M
Cost of Goods Sold	123,0M	96,6M	66,1M	33,3M	17,6M
Gross Profit	679,8M	528,2M	341,7M	200,1M	97,8M
Operating Expenses	643,7M	568,5M	389,3M	240,0M	154,0M
Operating Income	36,1M	-40,3M	-47,6M	-39,8M	-56,2M
Pre-tax Income	58,5M	-19,9M	-44,3M	-42,0M	-57,1M
Income Tax	4,9M	1,2M	613,0K	72,0K	115,0K
Net Income	53,5M	-21,2M	-44,9M	-42,0M	-57,2M
EPS (Diluted)	1,75 US$	-0,72 US$	-1,60 US$	-1,54 US$	-2,19 US$

Income Statement Trend

Balance Sheet

Metric	2024	2023	2022	2021	2020
Assets
Current Assets	630,8M	593,7M	530,0M	268,5M	269,9M
Non-Current Assets	177,6M	83,1M	34,8M	26,5M	11,3M
Total Assets	808,4M	676,8M	564,9M	295,1M	281,2M
Liabilities
Current Liabilities	88,5M	78,1M	61,2M	41,3M	20,7M
Non-Current Liabilities	30,2M	26,2M	7,7M	24,7M	30,7M
Total Liabilities	118,7M	104,3M	68,9M	66,0M	51,4M
Equity
Total Shareholders Equity	689,7M	572,5M	496,0M	229,0M	229,7M

Balance Sheet Composition

Cash Flow Statement

Metric	2024	2023	2022	2021	2020
Operating Activities
Net Income	53,5M	-21,2M	-44,9M	-42,0M	-57,2M
Operating Cash Flow	129,4M	25,0M	2,4M	-26,5M	-54,6M
Investing Activities
Capital Expenditures	-39,1M	-23,6M	-9,1M	-4,7M	-2,5M
Investing Cash Flow	-113,1M	-294,8M	-19,6M	29,1M	86,6M
Financing Activities
Dividends Paid	-	-	-	-	-
Financing Cash Flow	-80,2M	-17,2M	219,3M	0	124,7M
Free Cash Flow	91,1M	1,0M	2,5M	-24,8M	-55,5M

Cash Flow Trend

Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) 58,07

Forward P/E 64,23

Price to Book 5,89

Price to Sales 4,46

PEG Ratio 64,23

Profitability Ratios

Profit Margin 7,92 %

Operating Margin -0,74 %

Return on Equity 10,86 %

Return on Assets 4,40 %

Financial Health

Current Ratio 9,01

Debt to Equity 5,27

Beta 1,29

Per Share Data

EPS (TTM) 2,19 US$

Book Value per Share 21,58 US$

Revenue per Share 28,21 US$

Peer Financial Comparison

Company	Market Cap	P/E Ratio	P/B Ratio	ROE	Profit Margin	Debt/Equity
insp	3,8B	58,07	5,89	10,86 %	7,92 %	5,27
Abbott Laboratories	236,0B	17,61	4,83	30,65 %	31,89 %	27,09
Boston Scientific	147,6B	72,80	6,64	9,50 %	11,58 %	52,16
Masimo	8,7B	129,16	9,24	-25,07 %	-23,25 %	72,01
Globus Medical	8,0B	43,96	1,95	4,63 %	7,39 %	2,27
Bio-Rad	6,8B	-3,83	1,03	-27,52 %	-85,16 %	20,50

Financial data is updated regularly. All figures are in the company's reporting currency.